As 2025 comes to a close, fiscal negotiations in Congress are intensifying, with significant implications for federal research budgets. Decisions on topline spending and appropriations will directly shape funding for agencies like the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Advanced Research Projects Agency for Health (ARPA-H), influencing grant availability,... Read More
The American Society of Human Genetics (ASHG) is deeply troubled by the recent layoffs at the National Institutes of Health (NIH), the Advanced Research Projects Agency for Health (ARPA-H), National Science Foundation (NSF) and other agencies. These abrupt and unilateral decisions have far-reaching consequences that extend beyond the immediate loss of jobs. The impact on... Read More
The American Society of Human Genetics released the following statement in response to the recent announcement from the National Institutes of Health (NIH) regarding the implementation of a 15% reimbursement rate cap for Facilities and Administration (F&A) costs, applicable to both new and existing grants as of February 10. Although a temporary restraining order is... Read More
For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More
The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More